Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers

Genes Chromosomes and Cancer

Volumn 45, Issue 11, 2006, Pages 983-994

  Benz, Christopher C ^a,b   Fedele, Vita ^a,b   Xu, Fan ^a   Ylstra, Bauke ^b,g   Ginzinger, David ^b   Yu, Mamie ^b   Moore, Dan ^b   Hall, Rayna Kneuper ^c   Wolff, Daynna J ^c   Disis, Mary L ^d   Eppenberger Castori, Serenella ^e   Eppenberger, Urs ^e   Schittulli, Francesco ^f   Tommasi, Stefania ^f   Paradiso, Angelo ^f   Scott, Gary K ^a   Albertson, Donna G ^b  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Stiftung Tumorbank Basel   (Switzerland)

^f NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA;

ALLELISM; AMPLICON; ARTICLE; BREAST CANCER; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ALLELES; ALTERNATIVE SPLICING; BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; GENOTYPE; HUMANS; MALE; NEOPLASM INVASIVENESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 33748948902     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20364     Document Type: Article

References (53)

1. Allen E, Horvath S, Tong F, Kraft P, Spiteri E, Riggs AD, Marahrens Y. 2003. High concentrations of long interspersed nuclear element sequence distinguish monoallelically expressed genes. Proc Natl Acad Sci USA 100:9940-9945.
2. Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. 2000. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci USA 97:3444-3449.
3. Andrechek ER, Laing MA, Girgis-Gabardo AA, Siegel PM, Cardiff RD, Muller WJ. 2003. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. Cancer Res 63:4920-4926.
4. Benusiglio PR, Lesuer F, Luccarini C, Conroy DM, Shah M, Easton DF, Day NE, Dunning AM, Pharoah PD, Ponder BAJ. 2005. Common ERBB2 polymorphisms and risk of breast cancer in a white British population: A case-control study. Breast Cancer Res 7:R204-R209.
5. Borst P, Genest P-A. 2006. Parasitology: Switching like for like. Nature 439:926, 927.
6. Buckland PR. 2004. Allele-specific gene expression differences in humans. Hum Mol Genet 13:R255-R260.
7. Burstein HJ. 2005. The distinctive nature of HER2-positive breast cancers. N Engl J Med 353:1652-1654.
8. Chess A. 1998. Expansion of the allelic exclusion principle. Science 279:2067, 2068.
9. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A. 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132-1139.
10. Doherty JK, Bond C, Jardim A, Adelman JP, Clinton GM. 1999. The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. Proc Natl Acad Sci USA 96:10869-10874.
11. Dotan ZA, Dotan A, Litmanovitch T, Ravia Y, Oniashvili N, Leibovitch I, Ramon J, Avivi L. 2000. Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma: A novel genetic alteration associated with malignancy. Genes Chromosomes Cancer 27:270-277.
12. Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F, MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, Ball S, Almeida M, Linardopoulos S, Balmain A. 2003. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 34:403-412.
13. Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R, Dairkee S, Tokuyasu T, Ljung BM, Jain AN, McLennan J, Ziegler J, Chin K, Devries S, Feiler H, Gray JW, Waldman F, Pinkel D, Albertson DG. 2006. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6:96.
14. Gimelbrant AA, Chess A. 2006. An epigenetic state associated with areas of gene duplication. Genome Res 16:723-729.
15. Gimelbrant AA, Ensminger AW, Qi P, Zucker J, Chess A. 2005. Monoallelic expression and asynchronous replication of p120 catenin in mouse and human cells. J Biol Chem 280:1354-1359.
16. Ginzinger DG. 2002. Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream. Exp Hematol 30:503-512.
17. Godfrey TE, Kim S-H, Chavira M, Ruff DW, Warren RS, Gray JW, Jensen RH. 2000. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn 2:84-91.
18. Hamilton G, Brown N, Oseroff V, Huey B, Segraves R, Sudar D, Kumler J, Albertson D, Pinkel D. 2006. A large field CCD system for quantitative imaging of microarrays. Nucleic Acids Res 34: e58.
19. Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L, Kerem B. 2002. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1:89-97.
20. Hosokawa Y, Arnold A. 1998. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: Analysis of allele-specific expression. Genes Chromosomes Cancer 22:66-71.
21. Ishii S, Imamoto F, Yamanashi Y, Toyoshima K, Yamamoto T. 1987. Characterization of the promoter region of the c-erbB2 protooncogene. Proc Natl Acad Sci USA 84:4374-4378.
22. Jain AN, Tokuyasu T, Snijders AM, Segraves R, Albertson DG, Pinkel D. 2001. Fully automatic quantification of microarray image data. Genome Res 12:325-332.
23. Jhabvala-Romero F, Evans A, Guo S, Denton M, Clinton GM. 2003. Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER2. Oncogene 22:8178-8186.
24. Kauraniemi P, Kallioniemi A. 2006. Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer. Endocr Relat Cancer 13:39-49.
25. Kraus MG, Popescu NC, Amsboough SC, King CR. 1987. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6:605-610.
26. Kuwahara Y, Tanabe C, Ikeuchi T, Aoyagi K, Nishigaki M, Sakamoto H, Hoshinaga K, Yoshida T, Sasaki H, Terada M. 2004. Alternative mechanisms of gene amplification in human cancers. Genes Chromosomes Cancer 41:125-132.
27. Liu E, Thor A, He M, Barcos M, Ljung B-M, Benz C. 1992. The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7:1027-1032.
28. Livak KJ, Schmittgen TD. 2001. Analysis of relative copy number data using real-time quantitative PCR and the 2(-Δ Δ C(T)) 2 method. Methods 25:402-408.
29. Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, Lee MP. 2003. Allelic variation in gene expression is common in the human genome. Genome Res 13:1855-1862.
30. Marx C, Berger C, Xu F, Amend C, Scott GK, Hann B, Park JW, Benz CC. 2006. Validated high-throughput screening of drug-like small molecules for inhibitors of ErbB2 transcription. Assay Drug Dev Technol 4:273-284.
31. Mizuguchi G, Kanei-Ishii C, Sawazaki T, Horikoshi M, Roeder RG, Yamamoto T, Ishii S. 1994. Independent control of transcription initiations from two sites by an initiator-like element and TATA box in the human c-erbB-2 promoter. FEBS Lett 348:80-88.
32. Neve RM, Ylstra B, Chang C-H, Albertson DG, Benz CC. 2002. ErbB2 activation of ESX gene expression. Oncogene 21:3934-3938.
33. Nezu M, Nishigaki M, Ishizuka T, Kuwahara Y, Tanabe C, Aoyagi K, Sakamoto H, Saito Y, Yoshida T, Sasaki H, Terada M. 2002. Identification of the CAB2/hCOS16 gene required for the repair of DNA double-strand breaks on a core amplified region of the 17q12 locus in breast and gastric cancers. Jpn J Cancer Res 93:1183-1186.
34. Nezu M, Sasaki H, Kuwahara Y, Ochiya T, Yamada Y, Sakamoto H, Tashiro H, Yamazaki M, Ikeuchi T, Saito Y, Terada M. 1999. Identification of a novel promoter and exons of the c-ERBB-2 gene. Biochem Biophys Res Commun 258:499-505.
35. Ohlsson R, Tycko B, Sapienza C. 1998. Monoallelic expression: 'There can only be one.' Trends Genet 14:435-438.
36. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo W-L, Chen C, Zhai Y, Dairkee SH, Ljung B-M, Gray JW, Albertson DG. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211.
37. Puget N, Knowlton M, Scully R. 2005. Molecular analysis of sister chromatid recombination in mammalian cells. DNA Repair 4:149-161.
38. Raziuddin A, Court D, Sarkar FH, Liu Y-L, Kung H, Raziuddin R. 1997. A c-erbB-2 promoter-specific nuclear matrix protein from human breast tumor tissues mediates NF-κB DNA binding activity. J Biol Chem 272:15715-15720.
39. Rhoades KL, Singh N, Simon I, Glidden B, Cedar H, Chess A. 2000. Allele-specific expression patterns of interleukin-2 and Pax-S revealed by a sensitive single-cell RT-PCR analysis. Curr Biol 10:789-792.
40. Savelyeva L, Schwab M. 2001. Amplification of oncogenes revisited: From expression profiling to clinical application. Cancer Lett 167:115-123.
41. Schnur ER, Weigel RJ. 2000. Monoallelic amplification of estrogen receptor-α expression in breast cancer. Cancer Res 60:2598-2601.
42. Scott GK, Chang CH, Erny KM, Xu F, Fredericks WJ, Rauscher FJ, III, Thor AD, Benz CC. 2000. Ets regulation of the erbB2 promoter. Oncogene 19:6490-6502.
43. Scott GK, Daniel JC, Xiong X, Maki RA, Kabat D, Benz CC. 1994. Binding of an Ets-related protein within the DNase-I hypersensitivity site of the HER2/neu promoter in human breast cancer cells. J Biol Chem 269:19848-19858.
44. Scott GK, Marden C, Xu F, Kirk L, Benz CC. 2002. Transcriptional repression of ErbB2 by historic deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen. Mol Cancer Ther 1:385-392.
45. Scott GK, Robles R, Park JW, Montgomery PA, Daniel J, Holmes WE, Lee J, Keller GA, Li WL, Fendly BM, Wood WI, Shephard HM, Benz CC. 1993. A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells. Mol Cell Biol 13:2247-2257.
46. Shykind BM. 2005. Regulation of odorant receptors: One allele at a time. Hum Mol Genet 14 (Suppl. 1):R33-R39.
47. Smith SL, Bowers NL, Betticher DC, Gautschi O, Ratschiller D, Hoban PR, Booton R, Santibanez-Koref MF, Heighway J. 2005. Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Brit J Cancer 93:719-729.
48. Snijders AM, Fridlyand J, Mans D, Segraves R, Jain AN, Pinkel D, Albertson DG. 2003. Shaping tumor and drug resistant genomes by instability and selection. Oncogene 22:4370-4379.
49. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D, Albertson DG. 2001. Assembly of microarrays for genomewide measurement of DNA copy number. Nat Genet 29:263, 264.
50. Tal M, King CR, Kraus MH, Ullrich A, Schlessinger J, Givol D. 1987. Human HER2 (neu) promoter: Evidence for multiple mechanisms for transcriptional initiation. Mol Cell Biol 7:2597-2601.
51. Wang G, Vasquez KM. 2004. Naturally occurring H-DNA-forming sequences are mutagenic in mammalian cells. Proc Natl Acad Sci USA 101:13448-13453.
52. Yan H, Dobbie Z, Gruber SB, Markowitz S, Romans K, Giardiello FM, Kinzler KW, Vogelstein B. 2002. Small changes in expression affect predisposition to tumorigenesis. Nat Genet 30:25, 26.
53. Yan H, Zhou W. 2003. Allelic variations in gene expression. Curr Opin Oncol 16:39-43.